Ballard Power reports Q3 FY25 revenue of $32.5M, beats estimates, narrows net loss, improves gross margin, driven by strong bus, rail, and heavy-duty mobility sales.
Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.
Franklin Templeton debuts five new single-state municipal bond ETFs — FTMA, FTMN, FTNJ, FTOH, and FTPA — offering tax-exempt income and low 0.35% expense ratios after converting from Putnam's tax-exempt funds.
Dynatrace shares are rising after it rolled out new AI-powered Azure cloud operations tools and deeper integrations with Microsoft's reliability services.
Risk sentiment deteriorated sharply on Thursday despite federal agencies reopening after the longest government shutdown in U.S. history, as investors aggressively repriced Fed rate-cut expectations following a wave of hawkish remarks from central bank officials.